Items where contributor is "Kraenzlin, Marius E."

2011

Meyer, U. and Romann, M. and Zahner, L. and Schindler, C. and Puder, J. J. and Kraenzlin, M. and Rizzoli, R. and Kriemler, S.. (2011) Effect of a general school-based physical activity intervention on bone mineral content and density: a cluster-randomized controlled trial. Bone, 48 (4). pp. 792-797.

Suter-Widmer, Isabelle and Kraenzlin, Marius E. and Meier, Christian. (2011) Primärer Hyperparathyreoidismus. Therapeutische Umschau, Vol. 68, H. 6. pp. 321-326.

Meier, Christian and Kränzlin, Marius E.. (2011) Calcium supplementation, osteoporosis and cardiovascular disease. Swiss Medical Weekly, Vol. 141 , w13260.

Dürsteler-MacFarland, Kenneth M. and Kowalewski, Roland and Bloch, Nicole and Wiesbeck, Gerhard A. and Kraenzlin, Marius E. and Stohler, Rudolf. (2011) Patients on injectable diacetylmorphine maintenance have low bone mass. Drug and alcohol review, Vol. 30, H. 6. pp. 577-582.

Rohrbach, Marianne and Vandersteen, Anthony and Yi?, Uluç and Serdaroglu, Gul and Ataman, Esra and Chopra, Maya and Garcia, Sixto and Jones, Kristi and Kariminejad, Ariana and Kraenzlin, Marius and Marcelis, Carlo and Baumgartner, Matthias and Giunta, Cecilia. (2011) Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA) : clinical, molecular and biochemical delineation. Orphanet journal of rare diseases : OJRD, Vol. 6. p. 46.

Lamy, O. and Kraenzlin, M.. (2011) [Osteoporosis: evaluation and fracture risk]. Revue médicale suisse, Vol. 7. pp. 1018-1019.

Kraenzlin, Marius E. and Meier, Christian. (2011) Parathyroid hormone analogues in the treatment of osteoporosis. Nature reviews. Endocrinology, Vol. 7, no. 11. pp. 647-656.

Rizzoli, R. and Kraenzlin, M. and Krieg, M. A. and Mellinghoff, H. U. and Lamy, O. and Lippuner, K.. (2011) Indications to teriparatide treatment in patients with osteoporosis. Swiss medical weekly, Vol. 141 , w13297.

2008

Meier, C. and Kraenzlin, M. E. and Bodmer, M. and Jick, S. S. and Jick, H. and Meier, C. R.. (2008) Use of thiazolidinediones and fracture risk. Archives of internal medicine, Vol. 168. pp. 820-825.

Fukada, T. and Civic, N. and Furuichi, T. and Shimoda, S. and Mishima, K. and Higashiyama, H. and Idaira, Y. and Asada, Y. and Kitamura, H. and Yamasaki, S. and Hojyo, S. and Nakayama, M. and Ohara, O. and Koseki, H. and Dos Santos, H. G. and Bonafe, L. and Ha-Vinh, R. and Zankl, A. and Unger, S. and Kraenzlin, M. E. and Beckmann, J. S. and Saito, I. and Rivolta, C. and Ikegawa, S. and Superti-Furga, A. and Hirano, T.. (2008) The zinc transporter SLC39A13/ZIP13 is required for connective tissue development : its involvement in BMP/TGF-beta signaling pathways. PLoS one, Vol. 3, H. 11 , e3642.

Kraenzlin, M. E. and Anliker, M. and Griesmacher, A.. (2008) [Laboratory assessment of osteoporosis]. Therapeutische Umschau, Vol. 65, H. 9. pp. 513-518.